Arteraai

ArteraAI is a precision medicine company specializing in AI-enabled predictive and prognostic cancer tests. Founded in 2015 by Andre Esteva, the company is headquartered in Los Altos, California, and operates across three continents. ArteraAI's flagship product, the ArteraAI Prostate Test, utilizes multimodal artificial intelligence to analyze patient data and personalize cancer therapy. The company generates revenue through the sale of these tests, which have been validated in multiple phase III clinical trials. Recently, ArteraAI secured $20 million in funding to further develop its technology and expand its market presence.

Recent Posts by Arteraai

1-20 of 56